Description Module
The Description Module contains narrative descriptions of the clinical trial, including a brief summary and detailed description. These descriptions provide important information about the study's purpose, methodology, and key details in language accessible to both researchers and the general public.
Description Module path is as follows:
Study -> Protocol Section -> Description Module
Description Module
Ignite Creation Date:
2025-12-25 @ 2:24 AM
Ignite Modification Date:
2025-12-25 @ 2:24 AM
NCT ID:
NCT00388934
Brief Summary:
Randomized nine months clinical comparison of implantation of Taxol eluting (Taxus Express) and Sirolimus eluting (Cypher Select) stents in non-selected patients with coronary artery disease.
Detailed Description:
Design:
* Randomized open multicentre trial.
Patients:
* 1800 patients with coronary artery disease scheduled for percutaneous coronary intervention with stent implantation.
Inclusion criteria:
* Patients with coronary artery disease scheduled for percutaneous coronary intervention with stent implantation.
* Signed informed consent.
Exclusion criteria:
* Participation in other stent studies.
Randomization:
* Implantation of Taxus Express og Cypher Select stents.
Primary end-point:
* Combined end-point of cardiac death, new revascularization (PCI or CABG) or myocardial infarction after nine months.
Secondary end-points:
* Total death after nine months
* Cardiac death after nine months
* Myocardial infarction after nine months
* Index vessel myocardial infarction after nine months
* Target lesion revascularization
* Target vessel revascularization
* Stent thrombosis after nine months
End-point evaluation:
* End-points will be adjudicated by an independent end-point committee
Study:
NCT00388934
Study Brief:
Protocol Section:
NCT00388934